Johnson & Johnson Patient Assistance Foundation Inc is located in New Brunswick, NJ. The organization was established in 1997. According to its NTEE Classification (E99) the organization is classified as: Health Care N.E.C., under the broad grouping of Health Care and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Johnson & Johnson Patient Assistance Foundation Inc is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, Johnson & Johnson Patient Assistance Foundation Inc generated $4.5b in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 26.4% each year . All expenses for the organization totaled $4.7b during the year ending 12/2022. While expenses have increased by 27.2% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990PF
Mission & Program ActivityExcerpts From the 990PF Filing
TAX YEAR
2022
Describe the Organization's Program Activity:
Part 3 - Line 4a
DISTRIBUTION OF PHARMACEUTICAL PRODUCTS TO NEEDY PERSONS ON A NON-DISCRIMINATORY BASIS WITHOUT CHARGE. (OVER 786,000 UNITS OF MEDICINES DONATED TO OVER 110,000 PATIENTS IN 2022)
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Lauren Moore President - Trustee | 5 | $0 | |
Kimberly Wortman Vice President - Trustee | 40 | $0 | |
Daryl Todd Secretary - Trustee | 3 | $0 | |
Casey Murphy-Gerry Treasurer - Trustee | 3 | $0 | |
Richard Cansfield Trustee | 3 | $0 | |
Margaret Forrestel Trustee | 3 | $0 |
Vendor Name (Service) | Service Year | Compensation |
---|---|---|
Lash Group | 12/30/22 | $10,052,267 |
Eversana Life Science Svcs Llc | 12/30/22 | $15,785,481 |
Accredo | 12/30/22 | $4,446,003 |
Us Oncology Corp Inc | 12/30/22 | $4,072,966 |
Caremetx | 12/30/22 | $2,151,303 |
Statement of Revenue | |
---|---|
Contributions, Gifts, Grants & Similar | $4,456,813,201 |
Interest on Savings | $76,399 |
Dividends & Interest | $0 |
Net Rental Income | $0 |
Net Gain on Sale of Assets | $0 |
Capital Gain Net Income | $0 |
Net ST Capital Gain | $0 |
Income Modifications | $0 |
Profit on Inventory Sales | $0 |
Other Income | $0 |
Total Revenue | $4,456,889,600 |
Statement of Expenses | |
---|---|
Compensation of officers, directors, trustees, etc | $0 |
Other employee salaries and wages | $0 |
Pension plans, employee benefits | $0 |
Interest | $0 |
Taxes | $0 |
Depreciation | $0 |
Occupancy | $0 |
Travel, conferences, and meetings | $0 |
Printing and publications | $106,774 |
Other expenses | $98,159,649 |
Total operating and administrative expenses | $99,010,073 |
Contributions, gifts, grants paid | $4,609,834,188 |
Total expenses and disbursements | $4,708,844,261 |
Balance Sheet | |
---|---|
Cash—non-interest-bearing | $5,855 |
Savings and temporary cash investments | $23,743,968 |
Net Accounts receivable | $0 |
Net Pledges Receivable | $0 |
Grants receivable | $0 |
Receivables from Officers, Directors, or Controlling Persons | $0 |
Net other notes and loans receivable | $0 |
Inventories for sale or use | $573,646,128 |
Prepaid expenses and deferred charges | $0 |
Net Investments - land, buildings, equipment | $0 |
Investments—mortgage loans | $0 |
Investments—other | $0 |
Net Land, buildings, and equipment | $0 |
Other assets | $0 |
Total assets | $597,395,951 |
Accounts payable and accrued expenses | $0 |
Grants payable | $0 |
Deferred revenue | $0 |
Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
Mortgages and other notes payable | $0 |
Other liabilities | $0 |
Total liabilities | $0 |